正大企业国际(03839.HK)附属拟收购浦城正大15.8%股权
格隆汇12月24日丨正大企业国际(03839.HK)宣布,于2020年12月24日,公司全资附属正大浦城和正大华中作为买方与浦城县生物化学厂和兴旅工艺品作为卖方签订框架协议。
卖方将根据在中国转让国有资产的规定启动出售目标股权程序;及待卖方取得政府批准该框架协议项下的交易,买方将根据该框架协议的条款向卖方支付2000万元人民币作为收购诚意金。目标股权乃指浦城县生物化学厂和兴旅工艺品在浦城正大分别持有15.27%和0.53%股权。
据悉,浦城正大成立于1995年8月24日,目前约有注册资本1.9亿元人民币,其主要从事制造及/或销售金霉素产品及其他相关产品。浦城正大于2019年12月31日的未经审核综合资产净值约7680万美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.